Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant

doi:10.5306/wjco.v13.i8.688

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4789)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

225

WORD

HTML

1929

Figures (1-4)

189

Tables (1-2)

162

Sum=2585

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

210

Download

506

Sum=716

Publishing Process of This Article

Item

Count

Browse

353

Download

1135

Sum=1488

Aug 24, 2022 (publication date) through Jul 7, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Aug 24, 2022; 13(8): 688-701
Published online Aug 24, 2022. doi: 10.5306/wjco.v13.i8.688

Full Size Figure Download Figure

Figure 1 Flow chart of eligible patients included in the analysis according to the diagnosis of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or mixed hepatocellular-cholangiocarcinoma on explant pathology (January 1998-July 2019, southern Brazil). LT: Liver transplant; HCC: Hepatocellular carcinoma; HCC-CC: Hepatocellular cholangiocarcinoma; ICC: Intrahepatic cholangiocarcinoma.

Citation: Brandão ABM, Rodriguez S, Fleck Jr AM, Marroni CA, Wagner MB, Hörbe A, Fernandes MV, Cerski CT, Coral GP. Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant. World J Clin Oncol 2022; 13(8): 688-701
URL: https://www.wjgnet.com/2218-4333/full/v13/i8/688.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i8.688